
Journal of Organometallic Chemistry p. 295 - 308 (1992)
Update date:2022-08-02
Topics:
Rheinwald, Gerd
Stoeckli-Evans, Helen
Suess-Fink, Georg
Dodecacarbonyltriruthenium reacts with sulphonic acids to give dinuclear ruthenium complexes containing μ2-η2-sulphonato bridges.The triphenylphosphine derivatives Ru2(CO)4<μ2-η2-OOS(O)R>2(PPh3)2 (1: R = CF3; 2: R = Me; 3: R = Et; 4: R = (+)-Camph; 5: R = Ph; 6: R = Tol) have been isolated and characterized; the molecular structure of 6 has been established by a single-crystal X-ray structure analysis.Compound 6 crystallizes in two different space group: in the space group A2/n ( a 17.602(2), b 16.659(2), c 20.5234(2) Angstroem, β 106.57(1) deg, Z = 4) with crystallographic C2 symmetry, and in the space group P21/n (a 17.566(1), b 15.539(1), c 37.889(4) Angstroem, β 93.84(1) deg, Z = 8 with two independent molecules (I and II) per asymmetric unit.The two ruthenium atoms are bridged by the two sulphonato ligands, the average Ru-Ru distances being 2.776(1) Angstroem for the three conformers.The CO groups are trans with respect to the bridging ligands, giving rise to a sawhorse-like structure.
Shenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Hubei Xinghuo Chemical Co., Ltd.,
Contact:13925817279 13907299441
Address:Xinghuo Fine Chemistry Industrial Park, Xiaochang County, Hubei Province, China
Huangshan Honghui Pharm Technology Co., Ltd.(expird)
website:http://www.honghuichem.com
Contact:18855958372
Address:Qingshan Wan No.1,Nanyuan Kou,SheXian Huangshan City,Anhui Province
Shanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Suzhou BEC Fine Chemicals Co., Ltd.
website:http://www.bek.com.cn
Contact:0512-68095917 18913193865
Address:6, Jin Shan Road, Suzhou New District, 215011 China Suzhou Nations Pharmaceutical Innovation Center Inside
Doi:10.1248/cpb.40.2681
(1992)Doi:10.1021/jm00071a008
(1993)Doi:10.1021/ja00026a044
(1991)Doi:10.1021/jm00056a006
(1993)Doi:10.1021/jo00059a062
(1993)Doi:10.1055/s-1992-26359
(1992)